INS and Obesity: Both Type I (insulin-insufficient) and Type II (obesity-associated insulin-resistant) diabetes increase susceptibility to infection with many pathogens and worsens infection outcomes in animal models and humans, most notably for Staphylococcus aureus, Burkholderia pseudomallei and Mycobacterium tuberculosis infections [9–13].